Page last updated: 2024-11-04

succinylcholine and Brugada Syndrome

succinylcholine has been researched along with Brugada Syndrome in 1 studies

Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.

Brugada Syndrome: An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KREUSCHER, H1
LANGE, HJ1
MUTTER, KH1
WENZEL, U1

Other Studies

1 other study available for succinylcholine and Brugada Syndrome

ArticleYear
[STUDIES ON FIBRILLATIONS AND MUSCULAR PAIN AFTER SUCCINYLCHOLINE AND THEIR CONTROL BY GALLAMINE].
    Der Anaesthesist, 1965, Volume: 14

    Topics: Adjuvants, Anesthesia; Anesthesia; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System

1965